Pharma Industry Mergers and Acquisitions Deals by Top Themes in 2022 – Thematic Intelligence
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Pharma Industry Mergers and Acquisitions Deals Report Overview
The pharma sector witnessed 784 M&A deals worth $126 billion in 2022. North America lead the M&A activity in 2022. The top themes driving M&A activity in the pharma sector in 2022 were rare disease and precision & personalized medicine.
The pharma industry M&A deals thematic intelligence report provides an overview of the global M&A activities in the pharma sector in 2022. The report identifies the themes driving most notable to deals announced in 2022 in the pharma sector.
Pharma Industry M&A Deals Activity by Regions
The key regions that drove pharma industry M&A deal activity in 2022 are North America, Europe, China, South & Central America, Middle East & Africa, and APAC Ex-China. North America continued to lead the M&A deal activity in the pharma sector with 385 deals worth $75 billion in 2022.
Pharma Industry M&A Deals Analysis by Regions, 2022 (%)
For more regional insights into the pharma industry M&A deals activity, download a free report sample
Pharma Industry M&A Deals Activity by Sub- Sectors
The key sub-sectors witnessing pharma industry M&A activity in 2022 were immunology, central nervous system, oncology, gastrointestinal, respiratory, infectious disease, musculoskeletal disorders, dermatology, genetic disorders, metabolic disorders, and ophthalmology. Immunology was the biggest sub-sector in 2022 in terms of M&A deal value.
Pharma Industry M&A Deals Analysis by Sub-Sectors
For more insights into the sub-sectors in the pharma industry M&A deals activity, download a free report sample
Pharma Industry M&A Activity: Top Themes
Some of the top themes that will drive pharma industry M&A activity are artificial intelligence, biosimilars, deal making, and ESG-Environmental.
Theme Map of Pharma Industry, 2023
To know more about the top themes that drove pharma industry M&A activity in 2022, download a free report sample
Pharma Industry Mergers and Acquisitions Deals Report Overview
Market Size (2022) | $126 billion |
Key Regions | North America, Europe, China, South & Central America, Middle East & Africa, and APAC Ex-China |
Key Sectors | Immunology, Central Nervous System, Oncology, Gastrointestinal, Respiratory, Infectious Disease, Musculoskeletal Disorders, Dermatology, Genetic Disorders, Metabolic Disorders, and Ophthalmology |
Segments Covered in the Report
Pharma Industry Mergers and Acquisitions Deals Regional Outlook (Value, $ Billion, 2022)
- North America
- Europe
- China
- South & Central America
- Middle East & Africa
- APAC Ex-China
Pharma Industry Mergers and Acquisitions Deals Sub-Sectors Outlook (Value, $ Billion, 2022)
- Immunology
- Central Nervous System
- Oncology
- Gastrointestinal
- Respiratory
- Infectious Disease
- Musculoskeletal Disorders
- Dermatology
- Genetic Disorders
- Metabolic Disorders
- Ophthalmology
Scope
- This report provides an overview of merger and acquisition activity globally in 2022 in Pharma Sector.
- It identifies the themes driving most notable to deals announced in 2022 in the Pharma Sector.
Reasons to Buy
- Companies who invest in the right themes become success stories; those who miss the big themes end up as failures. If you want to understand the themes that drive an industry, simply look at the list of recent mergers and acquisitions (M&A).
- In this report we have listed down the most notable deals in pharma sector to make it easy for our clients to get a view of themes disrupting the sector and prepare for the future.
Pfizer
Takeda Pharma
Bristol Myers Squibb
Biocon Biologics
Thermo Fisher Scientific
Samsung Biologics
GSK
UCB
Sumitovant Biopharma
Incyte
Merck & Co
Eli Lilly
Social Capital Suvretta
Global Cord Blood
Merck Group
Formycon
Collegium Pharma
Isleworth Healthcare
LG Chem
Horizon Therapeutics
Biohaven Pharma
Nimbus Therapeutics
Turning Point Therapeutics
Viatris
The Binding Site Group
Biogen
Sierra Oncology
Zogenix
Myovant Sciences
Villaris Therapeutics
Imago BioSciences
Akouos
ProKidney
Cellenkos
Exelead
Athos
BioDelivery Sciences
Cytovia
AVEO Oncology
Table of Contents
Frequently asked questions
-
What was the pharma industry M&A deal activity size in 2022?
The global pharma industry M&A market witnessed deals worth $126 billion in 2022.
-
Which was the leading region in the pharma industry M&A deal activity in 2022?
North America led the pharma industry M&A deal activity in 2022 among all the other regions.
-
Which was the leading sector in the pharma industry M&A deal activity?
Immunology was the leading sector in the pharma industry M&A deal activity.
-
Which themes will drive the pharma industry M&A activity in 2023?
In 2023, the top themes that will drive pharma industry M&A activity are artificial intelligence, biosimilars, deal making, and ESG-environmental.

Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Pharmaceuticals reports

